Welcome to our dedicated page for Corecivic SEC filings (Ticker: CXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreCivic, Inc. filings document the public-company record for a Maryland corporation with common stock listed on the New York Stock Exchange under CXW. Form 8-K disclosures report quarterly financial results and guidance, material credit agreement amendments, revolving credit and term loan arrangements, share repurchase authorization, and executive appointments.
Proxy materials cover annual meeting voting matters, board governance, compensation and shareholder procedures. The filing record also documents securities registration details, capital structure actions, and formal exhibits such as earnings releases and credit facility amendments tied to the company’s corrections, detention, reentry and government real estate operations.
CoreCivic, Inc.’s Chief Administrative Officer Cole G. Carter sold 12,500 shares of Common Stock in an open-market transaction at $21.00 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by Carter. Following this transaction, he directly holds 215,883 shares, indicating he retains a substantial ongoing equity stake in the company.
Cole G Carter reported dispositions of Company common stock by sale. The disclosure lists three separate sales of 12,500 shares each on 03/02/2026, 04/01/2026 and 05/01/2026, with proceeds of $219,750, $236,212 and $257,680 respectively. The filing also records an RSU vesting event of 73,348 shares on 03/06/2025.
CoreCivic, Inc. reported the voting results of its 2026 annual meeting of stockholders, held by live webcast. Stockholders representing 89,552,695 shares of common stock, or 90.56% of the 98,886,782 shares outstanding and entitled to vote, were present in person or by proxy.
All eleven director nominees received strong support and were elected to serve until the 2027 annual meeting. Stockholders also ratified Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved on an advisory basis the compensation of the company’s named executive officers.
CoreCivic, Inc. Schedule 13G/A (Amendment No. 4) reports that Cooper Creek Partners Management LLC, via John McCleary, beneficially owns 2,849,459 shares of CoreCivic common stock (CUSIP 21871N101), representing 2.7% of the class. The filing is signed by John McCleary as CFO on 05/15/2026.
Emkes Mark A reported acquisition or exercise transactions in this Form 4 filing.
CoreCivic, Inc. director Mark A. Emkes received an equity award in the form of restricted stock units. He was granted 2,824 RSUs on the grant date, each representing one share of common stock, at a reference price of $21.25 per share. These RSUs vest in full on the first anniversary of the grant date, as long as he continues serving with the company through that vesting date. Following this award, he holds 171,274 shares of common stock directly, so the grant represents a relatively small addition to his existing stake.
CoreCivic reported strong Q1 2026 results, with revenue rising to $614.7 million and net income increasing to $37.9 million, or $0.38 per diluted share. Growth was driven mainly by higher federal revenue from U.S. Immigration and Customs Enforcement, as new and reactivated ICE contracts boosted average occupancy and per‑diem rates. Operating costs also climbed with wage increases, staffing for added capacity, and startup expenses at several facilities, though employee retention credits partially offset these pressures. Cash rose to $209.7 million while total debt expanded to $1.41 billion as the company funded share repurchases and capacity growth.
CoreCivic reported a strong first quarter of 2026, boosted by facility activations and higher federal and state populations. Total revenue rose to $614.7 million, up 25.8% from a year earlier. Net income increased to $37.9 million, or $0.38 per diluted share, with Adjusted Diluted EPS at $0.40.
Profitability improved, with Adjusted EBITDA reaching $110.1 million, up 36.0%, and Normalized FFO per diluted share rising to $0.65. The company repurchased 2.3 million shares for $44.7 million, and leverage stood at 2.8x net debt to Adjusted EBITDA.
CoreCivic completed a roughly $148.0 million acquisition of Clinical Solutions Pharmacy, expects it to add $0.03–$0.05 per share in 2026, and raised full-year 2026 guidance for net income, EPS, FFO and Adjusted EBITDA. Updated guidance incorporates the CSP acquisition and the Midwest Regional Reception Center activation, while acknowledging a recent decrease in nationwide ICE populations.
CoreCivic, Inc. Amendment No. 3 to a Schedule 13G/A: River Road Asset Management, LLC reports beneficial ownership of 9,011,396 shares of Common Stock, representing 9.1% of the class. The filer reports sole voting power for 7,758,282 shares and sole dispositive power for 9,011,396 shares. The filing is signed on 05/05/2026 and shows a date of 03/31/2026 on the cover.
CoreCivic, Inc. Chief Administrative Officer Cole G. Carter executed an open-market sale of 12,500 shares of common stock at $20.64 per share. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan, and Carter continues to directly hold 228,383 shares after the sale.
CXW submitted a Rule 144 notice reporting proposed and completed transactions in Common Stock. The filing records an RSU vesting event of 73,348 shares on 03/06/2025 and two reported dispositions by Cole G Carter: 12,500 shares sold on 03/02/2026 for $219,750.00 and 12,500 shares sold on 04/01/2026 for $236,212.00. Other header figures shown include 12500, $254,875.00, and 98,890,000 with an as of date 05/01/2026.